
Lei Yao
Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1328 |
| Issued Applications | 662 |
| Pending Applications | 127 |
| Abandoned Applications | 552 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9312016
[patent_doc_number] => 08653234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-18
[patent_title] => 'Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides'
[patent_app_type] => utility
[patent_app_number] => 13/535303
[patent_app_country] => US
[patent_app_date] => 2012-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 35
[patent_no_of_words] => 21533
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13535303
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/535303 | Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides | Jun 26, 2012 | Issued |
Array
(
[id] => 8649117
[patent_doc_number] => 20130034848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-07
[patent_title] => 'TUMOR SUPPRESSOR GENE P33ING2'
[patent_app_type] => utility
[patent_app_number] => 13/530070
[patent_app_country] => US
[patent_app_date] => 2012-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 27818
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13530070
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/530070 | TUMOR SUPPRESSOR GENE P33ING2 | Jun 20, 2012 | Abandoned |
Array
(
[id] => 8453182
[patent_doc_number] => 20120264129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'K-ras Mutations and Anti-EGFr Antibody Therapy'
[patent_app_type] => utility
[patent_app_number] => 13/523174
[patent_app_country] => US
[patent_app_date] => 2012-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12523
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13523174
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/523174 | K-ras mutations and anti-EGFr antibody therapy | Jun 13, 2012 | Issued |
Array
(
[id] => 8567143
[patent_doc_number] => 20120329713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'METHOD FOR DETERMINING LIKELIHOOD OF CLINICAL RECURRENCE OR CLINICALLY STABLE DISEASE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY'
[patent_app_type] => utility
[patent_app_number] => 13/489430
[patent_app_country] => US
[patent_app_date] => 2012-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 32208
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13489430
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/489430 | METHOD FOR DETERMINING LIKELIHOOD OF CLINICAL RECURRENCE OR CLINICALLY STABLE DISEASE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY | Jun 4, 2012 | Abandoned |
Array
(
[id] => 8846442
[patent_doc_number] => 08455624
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-04
[patent_title] => 'Methods and compositions for detecting endometrial or ovarian cancer'
[patent_app_type] => utility
[patent_app_number] => 13/487026
[patent_app_country] => US
[patent_app_date] => 2012-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26580
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13487026
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/487026 | Methods and compositions for detecting endometrial or ovarian cancer | May 31, 2012 | Issued |
Array
(
[id] => 9882762
[patent_doc_number] => 08969527
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-03
[patent_title] => 'Recurrent gene fusions in prostate cancer'
[patent_app_type] => utility
[patent_app_number] => 13/483142
[patent_app_country] => US
[patent_app_date] => 2012-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 85
[patent_figures_cnt] => 38
[patent_no_of_words] => 46921
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13483142
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/483142 | Recurrent gene fusions in prostate cancer | May 29, 2012 | Issued |
Array
(
[id] => 8502492
[patent_doc_number] => 20120301900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'APPARATUS AND METHOD FOR DETECTING TUMOR CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/479987
[patent_app_country] => US
[patent_app_date] => 2012-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6874
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13479987
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/479987 | APPARATUS AND METHOD FOR DETECTING TUMOR CELLS | May 23, 2012 | Abandoned |
Array
(
[id] => 8465634
[patent_doc_number] => 20120270802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'BINDING MOLECULES FOR THE TREATMENT OF MYELOID CELL MALIGNANCIES'
[patent_app_type] => utility
[patent_app_number] => 13/474456
[patent_app_country] => US
[patent_app_date] => 2012-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 27838
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13474456
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/474456 | Binding molecules for the treatment of myeloid cell malignancies | May 16, 2012 | Issued |
Array
(
[id] => 8381821
[patent_doc_number] => 20120225441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'PROTEIN MARKERS FOR DETECTING LIVER CANCER AND METHOD FOR IDENTIFYING THE MARKERS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/473064
[patent_app_country] => US
[patent_app_date] => 2012-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 6085
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13473064
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/473064 | PROTEIN MARKERS FOR DETECTING LIVER CANCER AND METHOD FOR IDENTIFYING THE MARKERS THEREOF | May 15, 2012 | Abandoned |
Array
(
[id] => 8381811
[patent_doc_number] => 20120225439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'PROTEIN MARKERS FOR DETECTING LIVER CANCER AND METHOD FOR IDENTIFYING THE MARKERS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/472995
[patent_app_country] => US
[patent_app_date] => 2012-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 6085
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13472995
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/472995 | PROTEIN MARKERS FOR DETECTING LIVER CANCER AND METHOD FOR IDENTIFYING THE MARKERS THEREOF | May 15, 2012 | Abandoned |
Array
(
[id] => 8382173
[patent_doc_number] => 20120225795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'PROTEIN MARKERS FOR DETECTING LIVER CANCER AND METHOD FOR IDENTIFYING THE MARKERS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/473019
[patent_app_country] => US
[patent_app_date] => 2012-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 6085
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13473019
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/473019 | PROTEIN MARKERS FOR DETECTING LIVER CANCER AND METHOD FOR IDENTIFYING THE MARKERS THEREOF | May 15, 2012 | Abandoned |
Array
(
[id] => 8381438
[patent_doc_number] => 20120225064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'Sphingosine 1-Phosphate Antagonism'
[patent_app_type] => utility
[patent_app_number] => 13/471441
[patent_app_country] => US
[patent_app_date] => 2012-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16707
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13471441
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/471441 | Sphingosine 1-Phosphate Antagonism | May 13, 2012 | Abandoned |
Array
(
[id] => 8476740
[patent_doc_number] => 20120276147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'CTSP CANCER-TESTIS ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 13/462351
[patent_app_country] => US
[patent_app_date] => 2012-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 31240
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13462351
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/462351 | CTSP cancer-testis antigens | May 1, 2012 | Issued |
Array
(
[id] => 8476597
[patent_doc_number] => 20120276004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'HUMAN MYELOID DERIVED SUPPRESSOR CELL CANCER MARKERS'
[patent_app_type] => utility
[patent_app_number] => 13/458788
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 18750
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13458788
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/458788 | Human myeloid derived suppressor cell cancer markers | Apr 26, 2012 | Issued |
Array
(
[id] => 10912913
[patent_doc_number] => 20140315929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'HSP90 COMBINATION THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/113779
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 74345
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113779
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/113779 | HSP90 COMBINATION THERAPY | Apr 26, 2012 | Abandoned |
Array
(
[id] => 9582453
[patent_doc_number] => 08772455
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-08
[patent_title] => 'Markers for identifying tumor cells, methods and kit thereof'
[patent_app_type] => utility
[patent_app_number] => 13/431919
[patent_app_country] => US
[patent_app_date] => 2012-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15734
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13431919
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/431919 | Markers for identifying tumor cells, methods and kit thereof | Mar 26, 2012 | Issued |
Array
(
[id] => 8495443
[patent_doc_number] => 20120294851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'Cancer Therapies and Pharmaceutical Compositions Used Therein'
[patent_app_type] => utility
[patent_app_number] => 13/428885
[patent_app_country] => US
[patent_app_date] => 2012-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 28209
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13428885
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/428885 | Cancer therapies and pharmaceutical compositions used therein | Mar 22, 2012 | Issued |
Array
(
[id] => 10032658
[patent_doc_number] => 09073964
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers'
[patent_app_type] => utility
[patent_app_number] => 13/422936
[patent_app_country] => US
[patent_app_date] => 2012-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 9
[patent_no_of_words] => 18341
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13422936
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/422936 | Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers | Mar 15, 2012 | Issued |
Array
(
[id] => 10032658
[patent_doc_number] => 09073964
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers'
[patent_app_type] => utility
[patent_app_number] => 13/422936
[patent_app_country] => US
[patent_app_date] => 2012-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 9
[patent_no_of_words] => 18341
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13422936
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/422936 | Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers | Mar 15, 2012 | Issued |
Array
(
[id] => 8405886
[patent_doc_number] => 20120237952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-20
[patent_title] => 'MYOSIN-IIA S1943 PHOSPHORYLATION AS A MARKER OF TUMOR INVASION'
[patent_app_type] => utility
[patent_app_number] => 13/419805
[patent_app_country] => US
[patent_app_date] => 2012-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4491
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13419805
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/419805 | Myosin-IIA S1943 phosphorylation as a marker of tumor invasion | Mar 13, 2012 | Issued |